Header Logo

Connection

WALLIS MOLCHEN to Bilirubin

Back to Details
This is a "connection" page, showing publications WALLIS MOLCHEN has written about Bilirubin.
WALLIS MOLCHEN
Connection Strength
0.044
Bilirubin
  1. Predicting clinical outcomes using baseline and follow-up laboratory data from the hepatitis C long-term treatment against cirrhosis trial. Hepatology. 2011 Nov; 54(5):1527-37.
    View in: PubMed
    Score: 0.044
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.